Back to Top

Durham-based drug developer Viamet plans to raise $75 million in IPO

Durham-based drug developer Viamet plans to raise $75 million in IPO

Viamet, co-founded in 2005 by former UNC-Chapel Hill Chancellor Holden Thorp, disclosed its plans in
See all stories on this topic

NCAA reopening North Carolina academic irregularities investigation

“The University of North Carolina at Chapel Hill has received a verbal notice of inquiry from t
See all stories on this topic


Comments

Write a comment

*